泰国伯克霍尔德菌临床分离株对甲氧苄啶/磺胺甲恶唑的耐药性 - Suppr

Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand.

作者信息

Saiprom Natnaree, Amornchai Premjit, Wuthiekanun Vanaporn, Day Nicholas P J, Limmathurotsakul Direk, Peacock Sharon J, Chantratita Narisara

机构信息

Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

出版信息

Int J Antimicrob Agents. 2015 May;45(5):557-9. doi: 10.1016/j.ijantimicag.2015.01.006. Epub 2015 Feb 16.

DOI:10.1016/j.ijantimicag.2015.01.006

PMID:25758020

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4537509/

Abstract

摘要

相似文献

Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand.

Int J Antimicrob Agents. 2015 May;45(5):557-9. doi: 10.1016/j.ijantimicag.2015.01.006. Epub 2015 Feb 16.

Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei.

Int J Antimicrob Agents. 2014 Oct;44(4):368-9. doi: 10.1016/j.ijantimicag.2014.06.003. Epub 2014 Jul 21.

Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.

Int J Antimicrob Agents. 2014 Aug;44(2):160-2. doi: 10.1016/j.ijantimicag.2014.04.012. Epub 2014 May 28.

The BpeEF-OprC efflux pump is responsible for widespread trimethoprim resistance in clinical and environmental Burkholderia pseudomallei isolates.

Antimicrob Agents Chemother. 2013 Sep;57(9):4381-6. doi: 10.1128/AAC.00660-13. Epub 2013 Jul 1.

Mechanisms of Resistance to Folate Pathway Inhibitors in : Deviation from the Norm.

mBio. 2017 Sep 5;8(5):e01357-17. doi: 10.1128/mBio.01357-17.

Antibiotic susceptibility of 50 clinical isolates of Burkholderia pseudomallei from Singapore.

J Antimicrob Chemother. 2006 Nov;58(5):1102-3. doi: 10.1093/jac/dkl359. Epub 2006 Sep 2.

Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam.

J Glob Antimicrob Resist. 2019 Sep;18:34-36. doi: 10.1016/j.jgar.2019.01.024. Epub 2019 Jan 24.

Five-year surveillance for Burkholderia pseudomallei in Thailand from 2000 to 2004: prevalence and antimicrobial susceptibility.

J Med Assoc Thai. 2009 Aug;92 Suppl 4:S46-52.

Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis.

Int J Antimicrob Agents. 2001 Feb;17(2):109-13. doi: 10.1016/s0924-8579(00)00334-4.

A comparison of antibiotic susceptibility testing methods for cotrimoxazole with Burkholderia pseudomallei.

Int J Antimicrob Agents. 2002 May;19(5):427-9. doi: 10.1016/s0924-8579(02)00016-x.

引用本文的文献

Improving the clinical recognition, prognosis, and treatment of melioidosis through epidemiology and clinical findings: The Sabah perspective.

PLoS Negl Trop Dis. 2023 Oct 16;17(10):e0011696. doi: 10.1371/journal.pntd.0011696. eCollection 2023 Oct.

Genomic and RT-qPCR analysis of trimethoprim-sulfamethoxazole and meropenem resistance in Burkholderia pseudomallei clinical isolates.

PLoS Negl Trop Dis. 2021 Feb 16;15(2):e0008913. doi: 10.1371/journal.pntd.0008913. eCollection 2021 Feb.

Antimicrobial Susceptibility of Western Hemisphere Isolates of : Phenotypic and Genomic Analyses.

Microb Drug Resist. 2021 Sep;27(9):1176-1185. doi: 10.1089/mdr.2020.0362. Epub 2021 Feb 10.

A Comparison Between 12 Versus 20 Weeks of Trimethoprim-sulfamethoxazole as Oral Eradication Treatment for Melioidosis: An Open-label, Pragmatic, Multicenter, Non-inferiority, Randomized Controlled Trial.

Clin Infect Dis. 2021 Dec 6;73(11):e3627-e3633. doi: 10.1093/cid/ciaa1084.

Human Melioidosis.

Clin Microbiol Rev. 2020 Mar 11;33(2). doi: 10.1128/CMR.00006-19. Print 2020 Mar 18.

Emerging role of biologics for the treatment of melioidosis and glanders.

Expert Opin Biol Ther. 2019 Dec;19(12):1319-1332. doi: 10.1080/14712598.2019.1677602. Epub 2019 Oct 15.

Pan-drug-resistant and biofilm-producing strain of : first report of melioidosis from a diabetic patient in Yogyakarta, Indonesia [Letter].

Int Med Case Rep J. 2019 Apr 18;12:117-118. doi: 10.2147/IMCRJ.S205245. eCollection 2019.

The relationship between bacterial sources and genotype to the antimicrobial resistance pattern of .

Vet World. 2018 Nov;11(10):1404-1408. doi: 10.14202/vetworld.2018.1404-1408. Epub 2018 Oct 12.

Melioidosis.

Nat Rev Dis Primers. 2018 Feb 1;4:17107. doi: 10.1038/nrdp.2017.107.

Case Report: Chorioamnionitis and Premature Delivery due to Infection in Pregnancy.

Am J Trop Med Hyg. 2018 Mar;98(3):797-799. doi: 10.4269/ajtmh.17-0789. Epub 2018 Jan 18.

本文引用的文献

Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei.

Int J Antimicrob Agents. 2014 Oct;44(4):368-9. doi: 10.1016/j.ijantimicag.2014.06.003. Epub 2014 Jul 21.

Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial.

Lancet. 2014 Mar 1;383(9919):807-14. doi: 10.1016/S0140-6736(13)61951-0. Epub 2013 Nov 25.

Melioidosis.

N Engl J Med. 2012 Sep 13;367(11):1035-44. doi: 10.1056/NEJMra1204699.

Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei.

J Antimicrob Chemother. 2005 Jun;55(6):1029-31. doi: 10.1093/jac/dki151. Epub 2005 May 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献